Abrocitinib Achieves Early and Complete/Near-Complete Skin Clearance Plus Itch-Free State in Atopic Dermatitis: Phase 3 Pooled Post Hoc Analysis - Top-Institutions - MDSpire

Abrocitinib Achieves Early and Complete/Near-Complete Skin Clearance Plus Itch-Free State in Atopic Dermatitis: Phase 3 Pooled Post Hoc Analysis

  • By

  • Stephen Weidinger

  • Kristian Reich

  • Naiem Issa

  • H. Chih-ho Hong

  • Christopher G. Bunick

  • Pinaki Biswas

  • Gary Chan

  • Erman Güler

  • Melissa Watkins

  • Justine Alderfer

  • June 27, 2026

  • 0 min

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai

    New York, New York

    Key Differentiators

    • Dermatology

  • #2

    Oregon Health & Science University
    Oregon Health & Science University

    Portland, Oregon

    Key Differentiators

    • Dermatology

Original Source(s)

Abrocitinib Achieves Early and Complete/Near-Complete Skin Clearance Plus Itch-Free State in Atopic Dermatitis: Phase 3 Pooled Post Hoc Analysis

  • by Stephen Weidinger, Kristian Reich, Naiem Issa, H. Chih-ho Hong, Christopher G. Bunick, Pinaki Biswas, Gary Chan, Erman Güler, Melissa Watkins, Justine Alderfer

  • June 27, 2026

Related Content

Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)

Analysis of Health Claims Data for German Patients with Atopic Dermatitis Not Adequately Managed by Standard Systemic Treatments

Minimal Systemic Exposure with Maximal Delgocitinib Cream Use in Patients with Severe Chronic Hand Eczema in the DELTA 2 Randomized, Vehicle-Controlled, Double-Blind, Phase 3 Trial